Skip to main content

Development of CPP-Based Methods for Delivery of miRNAs into the Skin and Airways: Lessons from Cell Culture and Mouse Models

  • Protocol
  • First Online:
Cell Penetrating Peptides

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2383))

Abstract

microRNAs (miRNAs) have capacity to modulate numerous biological processes and therefore synthetic oligonucleotides mimicking or inhibiting particular miRNA have potential in the development of novel types of therapeutics. We have elaborated several methods for safe and efficient overexpression of miRNAs using self-forming nanocomplexes of PepFect or NickFect type of cell-penetrating peptides (CPPs) and oligonucleotides mimicking well-characterized anti-inflammatory miR-146a. We focus on chronic inflammatory diseases affecting epithelium, such as atopic dermatitis and asthma harnessing respective cell cultures and mouse models. Here we provide protocols for miRNA transfection into primary human keratinocytes, primary human bronchial epithelial cells, and human monocyte-derived dendritic cells using CPPs PepFect14, NickFect70, NickFect71, and NickFect72. In addition, we provide protocols for application of CPP-miRNA nanocomplexes in in vivo mouse models of irritant contact dermatitis and allergic airway inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Makeyev EV, Maniatis T (2008) Multilevel regulation of gene expression by microRNAs. Science 319(5871):1789–1790

    Article  CAS  Google Scholar 

  2. Izaurralde E (2015) GENE REGULATION. Breakers and blockers-miRNAs at work. Science 349(6246):380–382

    Article  CAS  Google Scholar 

  3. O’Connell RM, Rao DS, Baltimore D (2012) microRNA regulation of inflammatory responses. Annu Rev Immunol 30:295–312

    Article  Google Scholar 

  4. Taganov KD et al (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103(33):12481–12486

    Article  CAS  Google Scholar 

  5. Kivihall A et al (2019) Reduced expression of miR-146a in human bronchial epithelial cells alters neutrophil migration. Clin Transl Allergy 9:62

    Article  CAS  Google Scholar 

  6. Crone SG et al (2012) microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-kappaB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer 11:71

    Article  CAS  Google Scholar 

  7. Rebane A et al (2014) MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. J Allergy Clin Immunol 134(4):836–847. e11

    Article  CAS  Google Scholar 

  8. Meisgen F et al (2014) MiR-146a negatively regulates TLR2-induced inflammatory responses in keratinocytes. J Invest Dermatol 134(7):1931–1940

    Article  CAS  Google Scholar 

  9. Rupaimoole R, Slack FJ (2017) MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 16(3):203–222

    Article  CAS  Google Scholar 

  10. Hu B et al (2020) Therapeutic siRNA: state of the art. Signal Transduct Target Ther 5(1):101

    Article  CAS  Google Scholar 

  11. Janssen HL et al (2013) Treatment of HCV infection by targeting microRNA. N Engl J Med 368(18):1685–1694

    Article  CAS  Google Scholar 

  12. Margus H, Padari K, Pooga M (2012) Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery. Mol Ther 20(3):525–533

    Article  CAS  Google Scholar 

  13. Urgard E et al (2016) Pre-administration of PepFect6-microRNA-146a nanocomplexes inhibits inflammatory responses in keratinocytes and in a mouse model of irritant contact dermatitis. J Control Release 235:195–204

    Article  CAS  Google Scholar 

  14. Gemma Carreras-Badosa JM, Periyasamy K, Urgard E, Padari K, Vaher H, Tserel L, Gestin M, Kisand K, Arukuusk P, Lou C, Langel Ü, Wengel J, Pooga M, Rebane A (2020) NickFect type of cell-penetrating peptides present enhanced efficiency for microRNA-146a delivery into dendritic cells and during skin inflammation. Biomaterials 262:120316

    Article  Google Scholar 

  15. Veiman KL et al (2013) PepFect14 peptide vector for efficient gene delivery in cell cultures. Mol Pharm 10(1):199–210

    Article  CAS  Google Scholar 

  16. Ezzat K et al (2011) PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation. Nucleic Acids Res 39(12):5284–5298

    Article  CAS  Google Scholar 

  17. Porosk L et al (2019) Enhancement of siRNA transfection by the optimization of fatty acid length and histidine content in the CPP. Biomater Sci 7(10):4363–4374

    Article  CAS  Google Scholar 

  18. Basler K et al (2016) The role of tight junctions in skin barrier function and dermal absorption. J Control Release 242:105–118

    Article  Google Scholar 

  19. Pasparakis M, Haase I, Nestle FO (2014) Mechanisms regulating skin immunity and inflammation. Nat Rev Immunol 14(5):289–301

    Article  CAS  Google Scholar 

  20. Laanesoo A et al (2021) Dual role of the miR-146 family in rhinovirus-induced airway inflammation and allergic asthma exacerbation. Clin Transl Med. 11:e427

    Google Scholar 

  21. Vaher H et al (2019) miR-10a-5p is increased in atopic dermatitis and has capacity to inhibit keratinocyte proliferation. Allergy 74(11):2146–2156

    Article  CAS  Google Scholar 

  22. Vaher H et al (2020) SERPINB2 and miR-146a/b are coordinately regulated and act in the suppression of psoriasis-associated inflammatory responses in keratinocytes. Exp Dermatol 29(1):51–60

    Article  CAS  Google Scholar 

  23. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179(4):1109–1118

    Article  CAS  Google Scholar 

  24. Tibbitt CA et al (2019) Single-cell RNA sequencing of the T helper cell response to house dust mites defines a distinct gene expression signature in airway Th2 cells. Immunity 51(1):169–184

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by European Regional Development Fund (Project No. 2014-2020.4.01.15-0012) from European Union, personal (PUT1669 for AR, PUT1617 for MP) from Estonian Research Council, Leo Foundation grant (LF17040) and Institute of Technology basic financing grant (PLTTI20912 to MP).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ana Rebane .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Laanesoo, A., Periyasamy, K., Pooga, M., Rebane, A. (2022). Development of CPP-Based Methods for Delivery of miRNAs into the Skin and Airways: Lessons from Cell Culture and Mouse Models. In: Langel, Ü. (eds) Cell Penetrating Peptides. Methods in Molecular Biology, vol 2383. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1752-6_32

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-1752-6_32

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-1751-9

  • Online ISBN: 978-1-0716-1752-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics